Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons.

The prevalence of GB virus C (GBV-C) infection is high in human immunodeficiency virus (HIV)-infected persons. However, the long-term consequences of coinfection are unknown. HIV-positive persons with a well-defined duration of infection were screened on the basis of their GBV-C/hepatitis G virus (HGV) RNA status and studied. GBV-C/HGV viremia was observed in 23, who carried the virus over a mean of 7.7 years. All parameters (survival, CDC stage B/C, HIV RNA load, CD4 T cell count) showed significant differences in terms of the cumulative progression rate between persons positive and negative for GBV-C/HGV RNA. When GBV-C/HGV RNA-positive and -unexposed subjects were matched by age, sex, baseline HIV RNA load, and baseline CD4 T cell count, HIV disease progression appeared worse in GBV-C/HGV RNA-negative subjects. The carriage of GBV-C/HGV RNA is associated with a slower progression of HIV disease in coinfected persons.

[1]  M. Manns,et al.  GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? , 1998, The Journal of infectious diseases.

[2]  F. Roudot-thoraval,et al.  The risk of disease progression is determined during the first year of human immunodeficiency virus type 1 infection. , 1998, The Journal of infectious diseases.

[3]  J. Takamatsu,et al.  Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[4]  P. Marcellin,et al.  GEMHEP multicenter quality control study of PCR detection of GB virus C/hepatitis G virus RNA in serum , 1997, Journal of clinical microbiology.

[5]  P. Sax.  Long-Term Nonprogressors , 1997 .

[6]  F. Roudot-thoraval,et al.  Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection. , 1997, Blood.

[7]  G. Davis,et al.  Effect of interferon-alpha and ribavirin therapy on serum GB virus C/hepatitis G virus (GBV-C/HGV) RNA levels in patients chronically infected with hepatitis C virus and GBV-C/HGV. , 1997, The Journal of infectious diseases.

[8]  L. Ferrell,et al.  Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation , 1997, Hepatology.

[9]  R. Wesley,et al.  The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. , 1997, The New England journal of medicine.

[10]  T. Surowy,et al.  An ELISA for detection of antibodies to the E2 protein of GB virus C. , 1997, The Journal of infectious diseases.

[11]  K. Stark,et al.  Detection of antibodies to a putative hepatitis G virus envelope protein , 1997, The Lancet.

[12]  T. Pilot‐Matias,et al.  Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker. , 1996, Virology.

[13]  R. Girot,et al.  Long-term persistence of hepatitis G virus in immunocompetent patients , 1996, The Lancet.

[14]  M. Mizokami,et al.  Hepatitis G virus in immunosuppressed paediatric allograft recipients , 1996, The Lancet.

[15]  J. Sheu,et al.  A prospective study of transfusion-transmitted GB virus C infection: similar frequency but different clinical presentation compared with hepatitis C virus. , 1996, Blood.

[16]  K. Masuko,et al.  Infection with hepatitis GB virus C in patients on maintenance hemodialysis. , 1996, New England Journal of Medicine.

[17]  H. Alter.  The cloning and clinical implications of HGV and HGBV-C. , 1996, The New England journal of medicine.

[18]  H. Margolis,et al.  Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent , 1996, Science.

[19]  S. Mishiro,et al.  Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology , 1995, The Lancet.

[20]  T. Pilot‐Matias,et al.  Identification of two flavivirus-like genomes in the GB hepatitis agent. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Margolick,et al.  Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. , 1995, The New England journal of medicine.

[22]  D. Ho,et al.  Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. , 1995, The New England journal of medicine.

[23]  D. van Strijp,et al.  A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes. , 1994, Journal of virological methods.

[24]  John W. Ward,et al.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[25]  D. van Strijp,et al.  NASBATM isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection , 1991 .

[26]  Joan S. Chmiel,et al.  Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Multicenter AIDS Cohort Study Group. , 1989, American journal of epidemiology.

[27]  J. Tran van Nhieu,et al.  Characteristics of patients with dual infection by hepatitis B and C viruses. , 1998, Journal of hepatology.

[28]  J. Phair,et al.  Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study. , 1992, Journal of acquired immune deficiency syndromes.

[29]  D. van Strijp,et al.  NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. , 1991, Journal of virological methods.

[30]  J. Chmiel,et al.  Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Multicenter AIDS Cohort Study Group. , 1989, American journal of epidemiology.

[31]  W. Dixon,et al.  BMDP statistical software , 1983 .